CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 39 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $75,210 | +21026.4% | 62,675 | -79.4% | 0.00% | – |
| Q1 2023 | $356 | -18.2% | 304,482 | -44.8% | 0.00% | – |
| Q4 2022 | $435 | -100.0% | 551,126 | -29.8% | 0.00% | -100.0% |
| Q3 2022 | $950,000 | -40.7% | 784,780 | -54.9% | 0.00% | 0.0% |
| Q2 2022 | $1,601,000 | +435.5% | 1,740,220 | +935.1% | 0.00% | – |
| Q1 2021 | $299,000 | +2890.0% | 168,128 | +1573.4% | 0.00% | – |
| Q4 2020 | $10,000 | -84.1% | 10,047 | -49.7% | 0.00% | – |
| Q3 2017 | $63,000 | – | 19,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| Syverson Strege & Co | 2,145 | $1,695 | 0.00% |